184241-44-9

NBI 27914 has been used as acorticotropin-releasing hormone receptor (CRHR1) antagonist:

• to study its effects on steroidogenic gene expression in GD15 mouse testis
• to study its effects on amyloid β production
• to study its effects on neurogenic activity of neural stem cells in the adult hippocampus

ChEBI: 5-chloro-N4-(cyclopropylmethyl)-2-methyl-N4-propyl-N6-(2,4,6-trichlorophenyl)pyrimidine-4,6-diamine is a dialkylarylamine and a tertiary amino compound.

Selective, non-peptide corticotropin-releasing factor 1 (CRF 1 ) receptor antagonist (K i = 1.7 nM); has no activity at CRF 2 receptors. Blocks behavioral seizures in vivo .

NBI 27914 is a CRF1 corticotropin-releasing factor receptor antagonist.